Wolfgang Miesbach on GTH Certification Program for Haemophilia Centres in German-Speaking Countries
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn:
”Quality Standards in Haemophilia Care: Five Years of Successful Center Certification
Thrilled to share our latest publication, led by Hermann Eichler, in Haemophilia Journal on the GTH certification program for haemophilia centres in German-speaking countries.
The Challenge
Specialized haemophilia centres have transformed outcomes for people with bleeding disorders, but consistent quality across centres is not a given. Building on the European EUHANET guidelines, the GTH developed its own structural and process quality guideline and launched an independent certification process in 2019.
The Methodology
Scope: Certification conceptually designed for Germany, Austria and Switzerland under the umbrella of GTH; all 23 certified centres so far are in Germany, with the first Swiss audit planned.
Centre types: Haemophilia Comprehensive Care Centres (≥40 patients with severe haemophilia A/B or vWD type 3) and Haemophilia Treatment Centres (≥10 patients).
Audit set-up: One-day on-site audit by two experienced haemophilia physicians specifically trained in quality management, supported by professional QM staff.
What was assessed: Compliance with GTH criteria on personnel, infrastructure, diagnostics, treatment (incl. surgery), registry participation and patient/relative education.
Governance: Scientific content by GTH; operational implementation and independence ensured by the accredited certification body ClarCert GmbH.
The Results
23 centres certified (2019–2024), based on 25 audits (including one repeat and one recertification).
Mean 2.8 nonconformities per audit (range 0–14), dropping to ~1.2 from 2021 onwards with better preparation and QM support.
On average 6 recommendations per centre, used to move beyond minimum standards toward continuous improvement.
Centres rated both the auditors and ClarCert as “excellent” (mean scores around 1.0–1.2 on a 1–4 scale), reflecting high trust and perceived added value rather than a purely administrative exercise.
17 Comprehensive Care Centres and 6 Treatment Centres now operate under a common, transparent quality framework.
In Germany, a valid certificate has become a prerequisite for haemophilia centres to conclude dedicated comprehensive-care contracts with health insurance bodies—linking measurable quality to funding and patient access.
The program also aligns national practice with evolving European accreditation efforts (EUHANET/European Association for Haemophilia and Allied Disorders (EAHAD)) while remaining pragmatic and scalable in daily clinical reality.”
Read the full article here.
Article: Five-Year Experience of Haemophilia Centre Certification Performed by the German, Austrian and Swiss Society for Thrombosis and Haemostasis Research
Authors: Hermann Eichler, Hagen Bönigk, Susan Halimeh, Christina Hart, Judith Hörner, Robert Klamroth, Ralf Knöfler, Christoph Königs, Thomas Lang, Florian Langer, Wolfgang Miesbach, Johannes Oldenburg, Ramona Oral, Martin Olivieri, Christian Pfrepper, Jan Pilch, Ute Scholz, Werner Streif, Manuela Albisetti
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 29, 2026, 17:25Robert Brodsky: Ravulizumab Appears To Be Safe And Effective In Pregnancy
-
Apr 29, 2026, 16:53Chokri Ben Lamine: IV Iron Showdown – FCM vs Ferric Derisomaltose vs Iron Dextran
-
Apr 29, 2026, 16:46Deep Vein Thrombosis Risk in Jobs with Prolonged Sitting – NBCA
-
Apr 29, 2026, 16:41Vikramaditya Gangakar: Essential Pharmacy Facts You Should Know About Aspirin
-
Apr 29, 2026, 16:17W. Alberto Sifuentes Giraldo: Non-Criteria Manifestations of Antiphospholipid Syndrome
-
Apr 29, 2026, 16:12Mavis Agnes Kisakye: Concluding a Successful Entrepreneurs Training for Empowering Ptients’ Mothers
-
Apr 29, 2026, 15:48Kriti Batni: Happy to Share Current Use and Future Directions of Monoclonal Antibodies in Medicine Update 2026
-
Apr 29, 2026, 15:46Dima Shulkin: Comparing HALP and PIV for Mortality Prediction in ACS
-
Apr 29, 2026, 15:44Sonal Sonu: Securing First Prize in Research Oral Presentation at the CME